interrupt the rapid growth phase, as it were short-circuiting the Gompertzian growth curve before the tumor regrowth achieved its mathematically greatest size gains.
Enabling this compressed dosing schedule was the development of granulocyte-colony stimulating factor, or G-CSF (filgrastim, Neupogen ® ). G-CSF serves to protect the patient's ability to make vital white blood cells during strenuous chemotherapy.
This new therapy approach has not been without its share of controversy, notes Dr. Norton, largely because the term "dose-dense" has been misinterpreted to mean "more toxic." In fact it may be just the opposite -as you will read. And dose density, with its compressed schedule, also holds promise of a shorter overall treatment time.
The Gompertzian curve also provided the seed for Dr. Norton's observations on a new understanding of cancer metastasis and cancer stem cell biology. He postulates that "self-metastasis" is responsible for small clumps of cell growth that together comprise a tumor, with each clump following the initial rapid growth of the Gompertzian model prior to distant metastasis.
"The bottom line is this," he writes. "We have tended to think that cancers metastasize because they are large; the reality may be that they are large because they are self-metastatic."
Dr. Larry Norton's recognition and appreciation for the utility of Gompertzian mathematics, spanning as it does the 19th and 20th centuries, is now during the early years of the 21st century being recognized for both its theoretical and practical importance. So this story really bridges three centuries. It also reflects the creativity and insightfulness of Dr. Norton -and his persistence too! 
